Pharmacokinetics of an anti—human immunodeficiency virus antisense oligodeoxynucleotide phosphorothioate (GEM 91) in HIV-infected subjects* (Q45787784)

From Wikidata

Jump to navigation Jump to search

scientific article published on July 1, 1995

Language	Label	Description	Also known as
English	Pharmacokinetics of an anti—human immunodeficiency virus antisense oligodeoxynucleotide phosphorothioate (GEM 91) in HIV-infected subjects*	scientific article published on July 1, 1995

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/7628182

Pharmacokinetics of an anti-human immunodeficiency virus antisense oligodeoxynucleotide phosphorothioate (GEM 91) in HIV-infected subjects (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/7628182

Pharmacokinetics of an anti—human immunodeficiency virus antisense oligodeoxynucleotide phosphorothioate (GEM 91) in HIV-infected subjects* (English)

1 reference

10.1016/0009-9236(95)90071-3

https://api.crossref.org/works/10.1016/0009-9236(95)90071-3

20 June 2024

0 references

pharmacokinetics

1 reference

based on heuristic

inferred from title

oligodeoxyribonucleotides, antisense

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7628182

20 June 2024

7

object named as

Saag MS

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/7628182

author name string

R. Zhang

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7628182

20 June 2024

J. Yan

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7628182

20 June 2024

H. K. Shahinian

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7628182

20 June 2024

G. Amin

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7628182

20 June 2024

Z. Lu

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7628182

20 June 2024

T. Liu

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7628182

20 June 2024

M. S. Saag

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7628182

20 June 2024

Z. Jiang

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7628182

20 June 2024

J. Temsamani

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7628182

20 June 2024

R. R. Martin

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7628182

20 June 2024

language of work or name

0 references

publication date

1 July 1995

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/7628182

Clinical Pharmacology & Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/7628182

58

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/7628182

1

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/7628182

44-53

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/7628182

Inhibition of replication and expression of human T-cell lymphotropic virus type III in cultured cells by exogenous synthetic oligonucleotides complementary to viral RNA.

1

1 reference

10.1016/0009-9236(95)90071-3

https://api.crossref.org/works/10.1016/0009-9236(95)90071-3

20 June 2024

Phosphorothioate analogs of oligodeoxynucleotides: inhibitors of replication and cytopathic effects of human immunodeficiency virus

2

1 reference

10.1016/0009-9236(95)90071-3

https://api.crossref.org/works/10.1016/0009-9236(95)90071-3

20 June 2024

Inhibition of human immunodeficiency virus replication by antisense oligodeoxynucleotides

3

1 reference

10.1016/0009-9236(95)90071-3

https://api.crossref.org/works/10.1016/0009-9236(95)90071-3

20 June 2024

Oligodeoxynucleoside phosphoramidates and phosphorothioates as inhibitors of human immunodeficiency virus

4

1 reference

10.1016/0009-9236(95)90071-3

https://api.crossref.org/works/10.1016/0009-9236(95)90071-3

20 June 2024

Regulation of viral expression of human immunodeficiency virus in vitro by an antisense phosphorothioate oligodeoxynucleotide against rev (art/trs) in chronically infected cells

5

1 reference

10.1016/0009-9236(95)90071-3

https://api.crossref.org/works/10.1016/0009-9236(95)90071-3

20 June 2024

Inhibition of human immunodeficiency virus in early infected and chronically infected cells by antisense oligodeoxynucleotides and their phosphorothioate analogues

6

1 reference

10.1016/0009-9236(95)90071-3

https://api.crossref.org/works/10.1016/0009-9236(95)90071-3

20 June 2024

Cholesteryl-conjugated oligonucleotides: synthesis, properties, and activity as inhibitors of replication of human immunodeficiency virus in cell culture

7

1 reference

10.1016/0009-9236(95)90071-3

https://api.crossref.org/works/10.1016/0009-9236(95)90071-3

20 June 2024

Inhibition of human immunodeficiency virus (HIV-1) replication by synthetic oligo-RNA derivatives

8

1 reference

10.1016/0009-9236(95)90071-3

https://api.crossref.org/works/10.1016/0009-9236(95)90071-3

20 June 2024

Specific inhibition of human immunodeficiency virus type 1 replication by antisense oligonucleotides: an in vitro model for treatment

11

1 reference

10.1016/0009-9236(95)90071-3

https://api.crossref.org/works/10.1016/0009-9236(95)90071-3

20 June 2024

Long-term treatment of human immunodeficiency virus-infected cells with antisense oligonucleotide phosphorothioates

12

1 reference

10.1016/0009-9236(95)90071-3

https://api.crossref.org/works/10.1016/0009-9236(95)90071-3

20 June 2024

Antisense phosphorothioate oligodeoxynucleotides targeted to the vpr gene inhibit human immunodeficiency virus type 1 replication in primary human macrophages

13

1 reference

10.1016/0009-9236(95)90071-3

https://api.crossref.org/works/10.1016/0009-9236(95)90071-3

20 June 2024

GEM 91--an antisense oligonucleotide phosphorothioate as a therapeutic agent for AIDS

17

1 reference

10.1016/0009-9236(95)90071-3

https://api.crossref.org/works/10.1016/0009-9236(95)90071-3

20 June 2024

Antisense oligodeoxynucleotide phosphorothioate complementary to Gag mRNA blocks replication of human immunodeficiency virus type 1 in human peripheral blood cells

18

1 reference

10.1016/0009-9236(95)90071-3

https://api.crossref.org/works/10.1016/0009-9236(95)90071-3

20 June 2024

Pharmacokinetics, biodistribution, and stability of oligodeoxynucleotide phosphorothioates in mice

19

1 reference

10.1016/0009-9236(95)90071-3

https://api.crossref.org/works/10.1016/0009-9236(95)90071-3

20 June 2024

Pharmacokinetics, biodistribution, and stability of capped oligodeoxynucleotide phosphorothioates in mice

21

1 reference

10.1016/0009-9236(95)90071-3

https://api.crossref.org/works/10.1016/0009-9236(95)90071-3

20 June 2024

Molecular Pharmacology

24

45

932

author name string

Sands H.

publication date

1994

1 reference

10.1016/0009-9236(95)90071-3

https://api.crossref.org/works/10.1016/0009-9236(95)90071-3

20 June 2024

Pharmacokinetics and tissue distribution in rats of an oligodeoxynucleotide phosphorothioate (GEM 91) developed as a therapeutic agent for human immunodeficiency virus type-1.

25

1 reference

10.1016/0009-9236(95)90071-3

https://api.crossref.org/works/10.1016/0009-9236(95)90071-3

20 June 2024

Large-scale synthesis, purification, and analysis of oligodeoxynucleotide phosphorothioates

26

1 reference

10.1016/0009-9236(95)90071-3

https://api.crossref.org/works/10.1016/0009-9236(95)90071-3

20 June 2024

Drug Metabolism and Disposition

31

20

113

author name string

Zhang R.

publication date

1992

1 reference

10.1016/0009-9236(95)90071-3

https://api.crossref.org/works/10.1016/0009-9236(95)90071-3

20 June 2024

Identifiers

10.1016/0009-9236(95)90071-3

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/7628182

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/7628182

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45787784&oldid=2184317638"